Nctid:
NCT00001331
Payload:
{"hasResults"=>false, "derivedSection"=>{"miscInfoModule"=>{"versionHolder"=>"2024-12-20"}, "conditionBrowseModule"=>{"meshes"=>[{"id"=>"D003882", "term"=>"Dermatomyositis"}, {"id"=>"D009220", "term"=>"Myositis"}, {"id"=>"D017285", "term"=>"Polymyositis"}, {"id"=>"D009135", "term"=>"Muscular Diseases"}, {"id"=>"D006014", "term"=>"Glycogen Storage Disease Type VII"}, {"id"=>"D006009", "term"=>"Glycogen Storage Disease Type II"}, {"id"=>"D006008", "term"=>"Glycogen Storage Disease"}, {"id"=>"D008659", "term"=>"Metabolic Diseases"}, {"id"=>"D004194", "term"=>"Disease"}], "ancestors"=>[{"id"=>"D009140", "term"=>"Musculoskeletal Diseases"}, {"id"=>"D009468", "term"=>"Neuromuscular Diseases"}, {"id"=>"D009422", "term"=>"Nervous System Diseases"}, {"id"=>"D003240", "term"=>"Connective Tissue Diseases"}, {"id"=>"D012871", "term"=>"Skin Diseases"}, {"id"=>"D010335", "term"=>"Pathologic Processes"}, {"id"=>"D002239", "term"=>"Carbohydrate Metabolism, Inborn Errors"}, {"id"=>"D008661", "term"=>"Metabolism, Inborn Errors"}, {"id"=>"D030342", "term"=>"Genetic Diseases, Inborn"}, {"id"=>"D020140", "term"=>"Lysosomal Storage Diseases, Nervous System"}, {"id"=>"D020739", "term"=>"Brain Diseases, Metabolic, Inborn"}, {"id"=>"D001928", "term"=>"Brain Diseases, Metabolic"}, {"id"=>"D001927", "term"=>"Brain Diseases"}, {"id"=>"D002493", "term"=>"Central Nervous System Diseases"}, {"id"=>"D016464", "term"=>"Lysosomal Storage Diseases"}, {"id"=>"D009136", "term"=>"Muscular Dystrophies"}, {"id"=>"D020966", "term"=>"Muscular Disorders, Atrophic"}], "browseLeaves"=>[{"id"=>"M12172", "name"=>"Myositis", "asFound"=>"Myositis", "relevance"=>"HIGH"}, {"id"=>"M9114", "name"=>"Glycogen Storage Disease", "asFound"=>"Glycogen Storage Disease", "relevance"=>"HIGH"}, {"id"=>"M12092", "name"=>"Muscular Diseases", "asFound"=>"Muscle Diseases", "relevance"=>"HIGH"}, {"id"=>"M7077", "name"=>"Dermatomyositis", "asFound"=>"Dermatomyositis", "relevance"=>"HIGH"}, {"id"=>"M19579", "name"=>"Polymyositis", "asFound"=>"Polymyositis", "relevance"=>"HIGH"}, {"id"=>"M9115", "name"=>"Glycogen Storage Disease Type II", "asFound"=>"Glycogen Storage Disease Type II", "relevance"=>"HIGH"}, {"id"=>"M9120", "name"=>"Glycogen Storage Disease Type VII", "asFound"=>"Glycogen Storage Disease Type VII", "relevance"=>"HIGH"}, {"id"=>"M11639", "name"=>"Metabolic Diseases", "asFound"=>"Storage Disease", "relevance"=>"HIGH"}, {"id"=>"M12097", "name"=>"Musculoskeletal Diseases", "relevance"=>"LOW"}, {"id"=>"M12411", "name"=>"Neuromuscular Diseases", "relevance"=>"LOW"}, {"id"=>"M6464", "name"=>"Connective Tissue Diseases", "relevance"=>"LOW"}, {"id"=>"M15674", "name"=>"Skin Diseases", "relevance"=>"LOW"}, {"id"=>"M11641", "name"=>"Metabolism, Inborn Errors", "relevance"=>"LOW"}, {"id"=>"M5498", "name"=>"Carbohydrate Metabolism, Inborn Errors", "relevance"=>"LOW"}, {"id"=>"M23686", "name"=>"Genetic Diseases, Inborn", "relevance"=>"LOW"}, {"id"=>"M18871", "name"=>"Lysosomal Storage Diseases", "relevance"=>"LOW"}, {"id"=>"M5204", "name"=>"Brain Diseases", "relevance"=>"LOW"}, {"id"=>"M5205", "name"=>"Brain Diseases, Metabolic", "relevance"=>"LOW"}, {"id"=>"M22498", "name"=>"Brain Diseases, Metabolic, Inborn", "relevance"=>"LOW"}, {"id"=>"M5742", "name"=>"Central Nervous System Diseases", "relevance"=>"LOW"}, {"id"=>"M12093", "name"=>"Muscular Dystrophies", "relevance"=>"LOW"}, {"id"=>"M4589", "name"=>"Atrophy", "relevance"=>"LOW"}, {"id"=>"M22697", "name"=>"Muscular Disorders, Atrophic", "relevance"=>"LOW"}, {"id"=>"T3001", "name"=>"Idiopathic Inflammatory Myopathy", "relevance"=>"LOW"}, {"id"=>"T1814", "name"=>"Dermatomyositis", "asFound"=>"Dermatomyositis", "relevance"=>"HIGH"}, {"id"=>"T4623", "name"=>"Polymyositis", "asFound"=>"Polymyositis", "relevance"=>"HIGH"}, {"id"=>"T2562", "name"=>"Glycogen Storage Disease Type 2", "asFound"=>"Glycogen Storage Disease Type II", "relevance"=>"HIGH"}, {"id"=>"T3963", "name"=>"Muscular Dystrophy", "relevance"=>"LOW"}], "browseBranches"=>[{"name"=>"Musculoskeletal Diseases", "abbrev"=>"BC05"}, {"name"=>"Nervous System Diseases", "abbrev"=>"BC10"}, {"name"=>"All Conditions", "abbrev"=>"All"}, {"name"=>"Diseases and Abnormalities at or Before Birth", "abbrev"=>"BC16"}, {"name"=>"Nutritional and Metabolic Diseases", "abbrev"=>"BC18"}, {"name"=>"Skin and Connective Tissue Diseases", "abbrev"=>"BC17"}, {"name"=>"Symptoms and General Pathology", "abbrev"=>"BC23"}, {"name"=>"Rare Diseases", "abbrev"=>"Rare"}]}}, "protocolSection"=>{"designModule"=>{"studyType"=>"OBSERVATIONAL"}, "statusModule"=>{"overallStatus"=>"COMPLETED", "startDateStruct"=>{"date"=>"1993-05"}, "expandedAccessInfo"=>{"hasExpandedAccess"=>false}, "statusVerifiedDate"=>"2002-03", "completionDateStruct"=>{"date"=>"2002-03"}, "lastUpdateSubmitDate"=>"2008-03-04", "studyFirstSubmitDate"=>"1999-11-03", "studyFirstSubmitQcDate"=>"1999-11-03", "lastUpdatePostDateStruct"=>{"date"=>"2008-03-05", "type"=>"ESTIMATED"}, "studyFirstPostDateStruct"=>{"date"=>"1999-11-04", "type"=>"ESTIMATED"}}, "conditionsModule"=>{"keywords"=>["Myopathy", "Phosphofructokinase", "Acid Maltase", "Pompe", "Muscle Diseases", "Genetic Muscle Diseases"], "conditions"=>["Dermatomyositis", "Glycogen Storage Disease Type II", "Glycogen Storage Disease Type VII", "Myositis", "Polymyositis"]}, "referencesModule"=>{"references"=>[{"pmid"=>"2662848", "type"=>"BACKGROUND", "citation"=>"Plotz PH, Dalakas M, Leff RL, Love LA, Miller FW, Cronin ME. Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med. 1989 Jul 15;111(2):143-57. doi: 10.7326/0003-4819-111-2-143."}, {"pmid"=>"1404746", "type"=>"BACKGROUND", "citation"=>"Plotz PH. Not myositis. A series of chance encounters. JAMA. 1992 Oct 21;268(15):2074-7. doi: 10.1001/jama.268.15.2074. No abstract available."}, {"pmid"=>"8444874", "type"=>"BACKGROUND", "citation"=>"Raben N, Sherman J, Miller F, Mena H, Plotz P. A 5' splice junction mutation leading to exon deletion in an Ashkenazic Jewish family with phosphofructokinase deficiency (Tarui disease). J Biol Chem. 1993 Mar 5;268(7):4963-7."}]}, "descriptionModule"=>{"briefSummary"=>"The purposes of this study are to identify gene mutations in patients with the muscle diseases phosphofructokinase (PFK) deficiency, acid maltase deficiency (GAA deficiency) and to learn more about how these diseases develop. PFK deficiency is a mild, exercise-related illness. The childhood form of GAA deficiency (Pompe disease) affects the heart and liver and is rapidly fatal. The adult form begins in midlife and involves degeneration of skeletal muscles, leading to weakness and muscle wasting.\n\nThe following groups of individuals may be eligible for this study:\n\nGroup A: Patients with PFK deficiency, acid maltase deficiency, and relatives who also are affected. Participants in this group will undergo a brief medical and family history, blood sample collection, and possibly a physical examination, review of medical records, and interview with the patient's physician.\n\nGroup B: Unaffected family members of patients in group A, including both blood relatives and spouses. People in this group may be asked to provide a history and genetic information. A review of medical records, interview with the individual's physician, and blood sample may also be requested.\n\nGroup C: Control subjects. This group will provide a small blood sample or buccal mucosal sample (tissue sample collected by brushing the inside of the cheek). The samples will be coded and the investigators will not know the participants' identities. DNA from these samples will be analyzed for frequency of gene mutations.\n\nGenetic counseling will be arranged for patients, as appropriate.", "detailedDescription"=>"This laboratory has defined several mutations in muscle diseases which mimic idiopathic inflammatory myopathy, (IIM, polymyositis or dermatomyositis), in particular, phosphofructokinase (PFK) deficiency (Type VII glycogenosis) and acid maltase (GAA) deficiency (Type II glycogenosis). Some patients with each of these autosomal recessive diseases have been shown to be genetic compounds, with different mutations on the alleles from each parent. In this protocol, we seek permission to receive and perform genetic screening on samples of tissue, blood, or DNA from patients with known metabolic muscle diseases, their family members, patients with undiagnosed muscle diseases, and groups of control subjects. Although we will know the names and histories of the patients, and may choose to admit them under other protocols for further studies, the tests we propose to perform on their DNA are currently only of laboratory interest and we believe that the outcome has no implications for the clinical care of the subjects. We propose to obtain oral consent, as appropriate to take a limited history and to speak to the patient's physician, from those patients and family members we speak to directly. All specimens obtained in family studies of a particular disease (e.g., PFK deficiency or GAA deficiency) will be obtained after written consent and will be tested only for the genes of the particular disease under study. After completion of those tests, the DNA, or products derived from it will be stored only under code so that it may be used as a control sample for other studies."}, "eligibilityModule"=>{"sex"=>"ALL", "stdAges"=>["CHILD", "ADULT", "OLDER_ADULT"], "healthyVolunteers"=>true, "eligibilityCriteria"=>"Patients known to have PFK deficiency, GAA deficiency or other known genetic muscle diseases and their clinically affected relatives.\n\nClinically unaffected family members of patients with PFK deficiency, GAA deficiency or other known genetic muscle diseases, including both blood relatives and spouses.\n\nControl subjects. These will be individuals whose DNA has been gathered and coded by other investigators and provided to us solely for the purpose of population surveys of mutation frequency. Among such controls, may be unaffected individuals of the same racial or geographic origin as those with a particular mutation. If a convenient bank of such anonymous samples is unavailable, we will seek such individuals among those who work at the NIH or their families or friends."}, "identificationModule"=>{"nctId"=>"NCT00001331", "briefTitle"=>"Genetic and Family Studies of Inherited Muscle Diseases", "organization"=>{"class"=>"NIH", "fullName"=>"National Institutes of Health Clinical Center (CC)"}, "officialTitle"=>"Genetic and Family Studies of Inherited Muscle Diseases", "orgStudyIdInfo"=>{"id"=>"930143"}, "secondaryIdInfos"=>[{"id"=>"93-AR-0143"}]}, "contactsLocationsModule"=>{"locations"=>[{"zip"=>"20892", "city"=>"Bethesda", "state"=>"Maryland", "country"=>"United States", "facility"=>"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)", "geoPoint"=>{"lat"=>38.98067, "lon"=>-77.10026}}]}, "sponsorCollaboratorsModule"=>{"leadSponsor"=>{"name"=>"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)", "class"=>"NIH"}}}}
